Veterinary Medicines

Glucobel 40 g/100 ml Infusionslösung für Pferde, Rinder, Schafe, Ziegen, Schweine, Hunde und Katzen

Authorised
  • Glucose monohydrate
Download as PDF

Product identification

Medicine name:
Glucobel 40 g/100 ml Infusionslösung für Pferde, Rinder, Schafe, Ziegen, Schweine, Hunde und Katzen
Glucobel vet, 40 g/100 ml infusionsvätska, lösning
Active substance:
  • Glucose monohydrate
Target species:
  • Cattle
  • Dog
  • Goat
  • Sheep
  • Horse
  • Cat
  • Pig
Route of administration:
  • Intravenous use

Product details

Active substance and strength:
  • Glucose monohydrate
    440.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for infusion
Withdrawal period by route of administration:
  • Intravenous use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        hour
    • Goat
      • Meat and offal
        0
        day
      • Milk
        0
        hour
    • Sheep
      • Meat and offal
        0
        day
      • Milk
        0
        hour
    • Horse
      • Meat and offal
        0
        day
      • Milk
        0
        hour
    • Pig
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QB05BA03
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Sweden
Available in:
  • Sweden
Package description:
  • 1 x 500 ml polypropylene bottle with bromobutyl stopper and aluminium cap
  • 1 x 750 ml polypropylene bottle with bromobutyl stopper and aluminium cap
  • 12 x 500 ml polypropylene bottle with bromobutyl stopper and aluminium cap
  • 12 x 750 ml polypropylene bottle with bromobutyl stopper and aluminium cap

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Well-established use application (Article 13a of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Bela-Pharm GmbH & Co. KG
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bela-Pharm GmbH & Co. KG
Responsible authority:
  • Swedish Medical Products Agency
Authorisation number:
  • 63340
Date of authorisation status change:
Reference member state:
  • Austria
Procedure number:
  • AT/V/0028/001
Concerned member states:
  • Denmark
  • Finland
  • Germany
  • Ireland
  • Netherlands
  • Norway
  • Portugal
  • Romania
  • Sweden

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Swedish (PDF)
Published on: 30/01/2023
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Swedish (PDF)
Published on: 30/01/2023
Download

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
Swedish (PDF)
Published on: 30/01/2023
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Swedish (PDF)
Published on: 30/01/2023
Download

Combined File of all Documents

English (PDF)
Published on: 6/12/2022
Download